Marie E. Lamont is General Manager of Inteliquet, a patient-matching clinical trial software company, having previously heald the roles of President and COO. She is the former president of the patient services business at Dohmen Life Science Services (DLSS), which was subsequently sold and is now part of EVERSANA. Prior to DLSS, Marie was global head of business strategy and commercial operations for rare disease at Sanofi Genzyme. She had stewardship for the $2.9B business.
.svg)
